Premature ovarian failure: an update

被引:202
作者
Anasti, JN
机构
[1] St Lukes Hosp, Dept Obstet & Gynecol, Bethlehem, PA 18015 USA
[2] NICHHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA
关键词
premature ovarian failure; ovarian dysfunction; ovarian physiology;
D O I
10.1016/S0015-0282(98)00099-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To present an overview of potential etiologies, clinical manifestations, and treatment modalities of premature ovarian failure (POF). Design: A search of past and current articles on basic ovarian physiology and POF with use of MEDLINE. Additional information was obtained from an active study section on POF at the National Institutes of Health. Specific sections of this manuscript summarize the strengths and weaknesses of the possible pathophysiologic processes and management options of POF as they appear in the literature. Result(s): POF is not an uncommon disorder. Although the etiology remains elusive in most cases, several rare specific causes have been discovered. Although POF was once thought to be permanent, a substantial number of patients experience spontaneous remissions. Because of the association with other autoimmune diseases, close follow-up is recommended in patients with POF. Hormone replacement therapy remains the cornerstone of treatment, and the best chance of achieving a pregnancy is through oocyte donation. Conclusion(s): An understanding of basic ovarian embryology and physiology will allow clinicians to apply current treatments and develop new innovative therapies for their patients with POF. (Fertil Steril(R) 1998;70:1-15. (C)1998 by American Society for Reproductive Medicine.).
引用
收藏
页码:1 / 15
页数:15
相关论文
共 101 条
  • [1] ADASHI EY, 1995, REPROD ENDOCRINOLOGY, P17
  • [2] ADRENAL AND STEROIDAL CELL ANTIBODIES IN PATIENTS WITH AUTOIMMUNE POLYGLANDULAR DISEASE TYPE-I AND RISK OF ADRENOCORTICAL AND OVARIAN FAILURE
    AHONEN, P
    MIETTINEN, A
    PERHEENTUPA, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (03) : 494 - 500
  • [3] THE EXPRESSION OF AUTOIMMUNE POLYGLANDULAR DISEASE TYPE-I APPEARS ASSOCIATED WITH SEVERAL HLA-A ANTIGENS BUT NOT WITH HLA-DR
    AHONEN, P
    KOSKIMIES, S
    LOKKI, ML
    TIILIKAINEN, A
    PERHEENTUPA, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (06) : 1152 - 1157
  • [4] Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene
    Aittomaki, K
    Herva, R
    Stenman, UH
    Juntunen, K
    Ylostalo, P
    Hovatta, O
    delaChapelle, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) : 3722 - 3726
  • [5] ALLANSON JE, 1986, OBSTET GYNECOL, V67, P74
  • [6] Amati P, 1996, AM J HUM GENET, V58, P1089
  • [7] Apoptosis in steroidogenic cells: Structure-function analysis
    Amsterdam, A
    Dantes, A
    Selvaraj, N
    Aharoni, D
    [J]. STEROIDS, 1997, 62 (01) : 207 - 211
  • [8] KARYOTYPICALLY NORMAL SPONTANEOUS PREMATURE OVARIAN FAILURE - EVALUATION OF ASSOCIATION WITH THE CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX
    ANASTI, JN
    ADAMS, S
    KIMZEY, LM
    DEFENSOR, RA
    ZACHARY, AA
    NELSON, LM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03) : 722 - 723
  • [9] ANASTI JN, 1994, FERTIL STERIL, V62, P726
  • [10] THE USE OF HUMAN RECOMBINANT GONADOTROPIN RECEPTORS TO SEARCH FOR IMMUNOGLOBULIN G-MEDIATED PREMATURE OVARIAN FAILURE
    ANASTI, JN
    FLACK, MR
    FROEHLICH, J
    NELSON, LM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) : 824 - 828